Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,387 | -15,649 | -11,718 | -6,767 | -10,364 |
| Depreciation Amortization | 131 | 102 | 60 | 29 | 89 |
| Other Working Capital | -225 | 429 | 230 | 155 | 657 |
| Other Operating Activity | 8,500 | 7,886 | 6,550 | 4,456 | 4,474 |
| Operating Cash Flow | $-9,981 | $-7,232 | $-4,879 | $-2,127 | $-5,145 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -76 | -28 | -26 | -23 | -88 |
| Purchase Sale Intangibles | N/A | -179 | -93 | -29 | N/A |
| Other Investing Activity | -256 | -179 | -93 | -29 | -122 |
| Investing Cash Flow | $-333 | $-207 | $-119 | $-53 | $-211 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 17,265 | 16,718 | 16,714 | 7,385 | 2,762 |
| Financing Cash Flow | $17,265 | $16,718 | $16,714 | $7,385 | $2,762 |
| Beginning Cash Position | 2,310 | 2,310 | 2,310 | 2,310 | 4,903 |
| End Cash Position | 9,261 | 11,589 | 14,026 | 7,515 | 2,310 |
| Net Cash Flow | $6,952 | $9,279 | $11,716 | $5,206 | $-2,594 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,981 | -7,232 | -4,879 | -2,127 | -5,145 |
| Capital Expenditure | -76 | -28 | -26 | -23 | -88 |
| Free Cash Flow | -10,058 | -7,260 | -4,905 | -2,150 | -5,233 |